TARRYTOWN, N.Y., May 5, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations as follows:
- J.P. Morgan 2017 Spring Conference Call Series at 10:00 a.m. Eastern Time on Thursday, May 11, 2017
- Bank of America Merrill Lynch 2017 Healthcare Conference at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) on Tuesday, May 16, 2017
- Barclays 2017 Biopharmaceuticals CEO/CFO Conference Call Series at 11:00 a.m. Eastern Time on Friday, May 19, 2017
The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. Archived versions of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-investor-conference-presentations-300452231.html
SOURCE Regeneron Pharmaceuticals, Inc.